用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [药品] 包含 'Acamprosate'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页123456下页尾页114 条记录, 当前第1/12页。
公开号 公开日 申请号 申请日
1. WO2014037412A1 2014/3/13 WO2013EP68302 2013/9/4
专利标题:NOOTROPIC COMPOSITIONS FOR IMPROVING MEMORY PERFORMANCE 法律状态
专利权人PHARNEXT [FR];
The invention relates to compositions and methods for improving memory and related functions as alertness, attention, concentration, learning, and language processing. More particularly, the invention relates to compositions comprising at least two drugs selected from cinacalcet, baclofen, acamprosate, mexiletine, sulfisoxazole and torasemide useful to enhance memory and related functions in healthy subjects or subjects suffering from conditions or disorders having a negative impact on their mem...


2. EP2705841A1 2014/3/12 EP20120306062 2012/9/5
专利标题:Combinations of nootropic agents for treating cognitive dysfunctions 法律状态
专利权人PHARNEXT [FR];
The invention relates to compositions and methods for improving memory and related functions as alertness, attention, concentration, learning, and language processing. More particularly, the invention relates to compositions comprising at least two drugs selected from cinacalcet, baclofen, acamprosate, mexiletine, sulfisoxazole and torasemide useful to enhance memory and related functions in healthy subjects or subjects suffering from conditions or disorders having a negative impact on their mem...


3. CN101492400B 2014/3/12 CN2008156550 2008/1/22
专利标题:A kind of preparation method of high-purity acamprosate calcium 法律状态


4. CN103596562A 2014/2/19 CN2012817651 2012/3/1
专利标题:Neurological disorder therapy based on baclofen and acamprosate 法律状态
专利权人


5. WO2014018468A1 2014/1/30 WO2013US51550 2013/7/22
专利标题:MODULATION SAPP, SAPP ALPHA AND BDNF LEVELS IN INDIVIDUALS DIAGNOSED WITH FXS AND ASD 法律状态
A method of treating and monitoring patient diagnosed with Autistic Spectrum disorder or Fragile X syndrome comprising measuring plasma biomarker levels of BDNF, sAPP, and sAPP alpha and adjusting the amount of a therapeutic compound according to the plasma levels of BDNF, sAPP and sAPPs. In one embodiment, the therapeutic compound is acamprosate.


6. EP2560631B1 2014/1/15 EP20120708113 2012/3/1
专利标题:Baclofen and acamprosate based therapy of neurogical disorders 法律状态
专利权人PHARNEXT;


7. US20130310456A1 2013/11/21 US13/891110 2013/5/9
专利标题:Acamprosate formulations, methods of using the same, and combinations comprising the same 法律状态
专利权人Synchroneuron Inc.;
Embodiments disclosed herein generally relate to acamprosate formulations methods of use of the formulations to methods of using the formulations in combination with at least one other medication and to combination products and compositions comprising the formulations and at least one other medication such as neuroleptic (antipsychotic) and/or antidepressant drugs.


8. US20130310455A1 2013/11/21 US13/891102 2013/5/9
专利标题:Acamprosate formulations, methods of using the same, and combinations comprising the same 法律状态
专利权人Synchroneuron Inc.;
Embodiments disclosed herein generally relate to acamprosate formulations methods of use of the formulations to methods of using the formulations in combination with at least one other medication and to combination products and compositions comprising the formulations and at least one other medication such as neuroleptic (antipsychotic) and/or antidepressant drugs.


9. US2013310456A1 2013/11/21 US201313891110 2013/5/9
专利标题:ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME 法律状态
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.


10. US2013310455A1 2013/11/21 US201313891102 2013/5/9
专利标题:ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME 法律状态
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.



首页123456下页尾页114 条记录, 当前第1/12页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文